Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Marijuana Abuse 2Pancreatic Cancer Non-resectable 1Pain 1Marijuana Use 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 2040Radiotherapy 1854Cisplatin 1820Carboplatin 1530Gemcitabine 1432Paclitaxel 1289Bevacizumab 1267Docetaxel 1200pembrolizumab 1196Oxaliplatin 1157Capecitabine 1140Fluorouracil 1059Dexamethasone 971Rituximab 918Nivolumab 908Magnetic Resonance Spectroscopy 858Etoposide 839Doxorubicin 823Drug Therapy 789Radiosurgery 774Irinotecan 774Cytarabine 736fludarabine 714Leucovorin 674Lenalidomide 608fludarabine phosphate 564Temozolomide 552Filgrastim 540Radiation 539Cetuximab 535

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Medical Marijuana × Clear all
NCT04827992 2025-11-05

Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain

Massachusetts General Hospital

Phase NA Completed
87 enrolled

Marijuana Use, Marijuana Abuse, Pain

NCT06605430 2025-07-29

CanPan-C

HealthPartners Institute

Phase 2 Recruiting
64 enrolled
Gastrointestinal

Pancreatic Cancer Non-resectable

NCT06518434 2024-07-24

CanHep

University Medical Center Groningen

Phase 2 Recruiting
20 enrolled
Gastrointestinal

Marijuana Abuse, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡